Senior insider sale
CEO at DICE THERAPEUTICS, INC. — senior position signals high conviction
$500.0K
13.70K shares
What this filing means
JUDICE KEVIN plans to sell 13.70K shares of DICE THERAPEUTICS, INC. valued at approximately $500.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/3/2023ACC: 0001973141-23-000020
DirectorOfficer· CEO
Since Sep 2021
13.70K
Shares to sell
$500.0K
Approx. market value
13.70K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock
CASH
11/15/2013
13.70KTotal acquired13.70K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/15/2013 | Restricted Stock CASH | 13.70K | — |
| Total | 13.70K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
13.70K
Market value
$500.0K
5/3/2023
Total
Units
13.70K
Value
$500.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/3/2023 | 13.70K | $500.0K | Nasdaq | Planned |
| Total | 13.70K | $500.0K | ||